Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Expression Rates in Invasive Breast Carcinoma: A Study of 21 Institutions

CONCLUSIONS.—: The data from this study provide multi-institutional benchmark data to assist laboratories performing periodic comparisons as part of a quality management program. Overall expression rates were generally similar to those of other published reports, with the exception of the ER-negative and HER2-positive rates, both of which were somewhat lower.PMID:38631690 | DOI:10.5858/arpa.2022-0384-CP

Source: Archives of Pathology and Laboratory Medicine - April 17, 2024 Category: Laboratory Medicine Authors: Daniel D Mais Alia N Nazarullah Anthony J Guidi Suzanne Dintzis Barbara J Blond Thomas A Long Suzanne N Coulter Richard W Brown Source Type: research